Bladder Cancer

Trial Protocol ID
USOR 18283_IMMU-132-06_TROPHY U-01

Investigator
Jun Sun, M.D.

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer

Learn More